Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/538,544external-prioritypatent/US5897475A/en
Application filed by Antex Biolog IncfiledCriticalAntex Biolog Inc
Priority claimed from NZ295877Aexternal-prioritypatent/NZ295877A/en
Publication of NZ333995ApublicationCriticalpatent/NZ333995A/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Abstract
A method for producing Helicobacter bacteria having enhanced antigenic properties which comprises growing a culture of the Helicobacter bacteria in vivo and a) a divalent cation chelator selected from 1.0-25ìM of BAPTA/AM, 0.5-10ìM EGTA and 1.0-100ìM EGTA/AM; b) at a temperature between 30-42oC; c) in air or an microaerophillic condition, wherein the microaerophillic condition comprises i) 5-20% CO2 with 80-95% air ii) 5-10% O2 with 10-20% CO2 with about 70-85% N2 for a sufficient time so that the culture is in a growth phase at about early log phase, between early log phase and stationary phase, or at about stationary phase, wherein the enhanced antigenic property is a higher level of immunogenic antigenicity when compared to the antigenic property of bacteria from a culture of Helicobacter species in brain heart infusion broth supplemented with bovine calf serum.
NZ333995A1994-10-051995-10-04Method and vaccine containing Helicobacter bacteria with antigenic properties
NZ333995A
(en)
A method for producing Helicobacter SP having enhanced antigenicity and a method comprising the same (METHODS FOR PRODUCING ENHANCED ANTIGENIC HELICOBACTER SP. AND VACCINES COMPRISING SAME)